BioLineRx Ltd.

April 16, 2018 .
Filer
BioLineRx Ltd.
Preview. View filing ...
6-K
0001178913-18-001191.nc
Current report of foreign issuer / company : Rules 13a-16 and 15d-16 Amendments. Includes: Material Events ( International )
Period of report
April 16, 2018
April 2, 2018 .
Filer
BioLineRx Ltd.
Preview. View filing ...
CT ORDER
9999999997-18-004061.nc
Confidential Treatment Orders
March 26, 2018 .
Filer
BioLineRx Ltd.
Preview. View filing ...
6-K
0001178913-18-000958.nc
Current report of foreign issuer / company : Rules 13a-16 and 15d-16 Amendments. Includes: Material Events ( International )
Period of report
March 26, 2018
March 12, 2018 .
Filer
BioLineRx Ltd.
Preview. View filing ...
6-K
0001178913-18-000798.nc
Current report of foreign issuer / company : Rules 13a-16 and 15d-16 Amendments. Includes: Material Events ( International )
Period of report
March 12, 2018
March 6, 2018 .
Filer
BioLineRx Ltd.
Preview. View filing ...
6-K
0001178913-18-000763.nc
Current report of foreign issuer / company : Rules 13a-16 and 15d-16 Amendments. Includes: Material Events ( International )
Period of report
March 6, 2018
March 6, 2018 .
Filer
BioLineRx Ltd.
Preview. View filing ...
20-F BLRX 
0001178913-18-000765.nc XBRL XML (6)
Registration statement Annual and transition report of foreign private issuers
Focus Period
2017 : FY
Fiscal year ends
--12-31
Period of report
Dec. 31, 2017
Feb. 27, 2018 .
Filer
BioLineRx Ltd.
Preview. View filing ...
6-K
0001178913-18-000701.nc
Current report of foreign issuer / company : Rules 13a-16 and 15d-16 Amendments. Includes: Material Events ( International )
Period of report
Feb. 27, 2018
Feb. 16, 2018, 12:50 p.m. ..
Filed For
BioLineRx Ltd.
Preview. View filing ...
UPLOAD
0000000000-18-000815.corr01
SEC-originated letters to filers
Feb. 16, 2018, 12:50 p.m. ..
Filer
BioLineRx Ltd.
Preview. View filing ...
CORRESP
0001178913-18-000182.corr01
Response letter to SEC outside of amended filings
Feb. 12, 2018 .
Filed By
Senvest Management, LLC
Subject Company
BioLineRx Ltd.
Preview. View filing ...
SC 13G/A
0000902664-18-000910.nc
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and institutions
Jan. 23, 2018 .
Filer
BioLineRx Ltd.
Preview. View filing ...
6-K
0001178913-18-000237.nc
Current report of foreign issuer / company : Rules 13a-16 and 15d-16 Amendments. Includes: Material Events ( International )
Period of report
Jan. 23, 2018
Jan. 23, 2018 .
Filer
BioLineRx Ltd.
Preview. View filing ...
6-K
0001178913-18-000235.nc
Current report of foreign issuer / company : Rules 13a-16 and 15d-16 Amendments. Includes: Material Events ( International )
Period of report
Jan. 23, 2018
Jan. 19, 2018 .
Filer
BioLineRx Ltd.
Preview. View filing ...
EFFECT
9999999995-18-000169.nc XML (1)
Notifications of effectiveness for registration statements issued by Division of Corporation Finance and Investment Management
3 months ago ...
Filer
BioLineRx Ltd.
Preview. View filing ...
F-3/A
0001178913-18-000197.nc
Registration statement for specified transactions by foreign private issuers ( International )
3 months ago ...
Filer
BioLineRx Ltd.
Preview. View filing ...
6-K
0001178913-18-000207.nc
Current report of foreign issuer / company : Rules 13a-16 and 15d-16 Amendments. Includes: Material Events ( International )
Period of report
Jan. 19, 2018
3 months ago ...
Filer
BioLineRx Ltd.
Preview. View filing ...
424B5
0001178913-18-000205.nc
Prospectus filed : Rule 424
Jan. 17, 2018 .
Filer
BioLineRx Ltd.
Preview. View filing ...
6-K
0001178913-18-000172.nc
Current report of foreign issuer / company : Rules 13a-16 and 15d-16 Amendments. Includes: Material Events ( International )
Period of report
Jan. 17, 2018
Dec. 28, 2017 .
Filer
BioLineRx Ltd.
Preview. View filing ...
F-3
0001178913-17-003489.nc
Registration statement for specified transactions by foreign private issuers ( International )
Dec. 28, 2017 .
Filer
BioLineRx Ltd.
Preview. View filing ...
6-K
0001178913-17-003491.nc
Current report of foreign issuer / company : Rules 13a-16 and 15d-16 Amendments. Includes: Material Events ( International )
Period of report
Dec. 28, 2017
Dec. 21, 2017 .
Filer
BioLineRx Ltd.
Preview. View filing ...
6-K
0001178913-17-003438.nc
Current report of foreign issuer / company : Rules 13a-16 and 15d-16 Amendments. Includes: Material Events ( International )
Period of report
Dec. 21, 2017
db